Senores Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	5,535	3,983	2,145	353.37	141.7
Revenue Growth (YoY)	43.20%	85.65%	507.07%	149.38%	-
Cost of Revenue	2,496	1,874	1,089	127.96	80.75
Gross Profit	3,038	2,108	1,057	225.41	60.95
Selling, General & Admin	998.1	636	363.1	51.75	28.92
Other Operating Expenses	469	575.1	277.5	46.93	12.51
Operating Expenses	1,739	1,380	740.8	116.47	48.48
Operating Income	1,300	728.8	315.8	108.94	12.47
Interest Expense	-206.9	-203.7	-85	-18.37	-5.1
Interest & Investment Income	71.6	71.6	4.6	0.39	1.93
Currency Exchange Gain (Loss)	34	34	10.7	34.21	2.68
Other Non Operating Income (Expenses)	125.8	75.2	3.6	-0.77	-0.55
EBT Excluding Unusual Items	1,324	705.9	249.7	124.4	11.43
Gain (Loss) on Sale of Assets	-0.2	-0.2	-0.3	-0.03	-
Pretax Income	1,324	705.7	249.4	124.37	11.43
Income Tax Expense	295.5	122.3	-77.6	40.04	1.52
Earnings From Continuing Operations	1,028	583.4	327	84.33	9.91
Minority Interest in Earnings	-12.4	2.2	-12.5	-	-
Net Income	1,016	585.6	314.5	84.33	9.91
Net Income to Common	1,016	585.6	314.5	84.33	9.91
Net Income Growth	79.28%	86.20%	272.94%	750.96%	-
Shares Outstanding (Basic)	45	36	23	10	5
Shares Outstanding (Diluted)	45	36	26	13	5
Shares Change (YoY)	27.75%	41.13%	103.16%	131.33%	-
EPS (Basic)	22.43	16.10	13.67	8.87	1.81
EPS (Diluted)	22.43	16.10	12.21	6.65	1.81
EPS Growth	40.32%	31.88%	83.61%	267.92%	-
Free Cash Flow	-	-2,034	-775.3	-483.56	-211.29
Free Cash Flow Per Share	-	-55.94	-30.09	-38.12	-38.53
Gross Margin	54.90%	52.94%	49.25%	63.79%	43.01%
Operating Margin	23.48%	18.30%	14.72%	30.83%	8.80%
Profit Margin	18.36%	14.70%	14.66%	23.86%	6.99%
Free Cash Flow Margin	-	-51.08%	-36.14%	-136.84%	-149.11%
EBITDA	1,502	882.4	404.8	109.55	12.61
EBITDA Margin	27.13%	22.16%	18.87%	31.00%	8.90%
D&A For EBITDA	202.05	153.6	89	0.61	0.14
EBIT	1,300	728.8	315.8	108.94	12.47
EBIT Margin	23.48%	18.30%	14.72%	30.83%	8.80%
Effective Tax Rate	22.32%	17.33%	-	32.19%	13.30%
Revenue as Reported	6,128	4,175	2,173	390.21	146.31
Advertising Expenses	-	32.3	8.5	3.82	0.31

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.